Cardiac Pacemakers Global Market Report 2022: Ukraine-Russia War Impact

News provided by

Dec 06, 2022, 08:00 ET

NEW YORK, Dec. 6, 2022 /PRNewswire/ --

Major players in the cardiac pacemakers market are Medtronic Plc, Lepu Medical Technology Co, Abbott Inc, Biotronik SE & Co KG, Boston Scientific Corporation, LivaNova PLC, Medico SRL, Osypka AG, Oscor Inc, MicroPort Scientific Corporation, Pacetronix, Zoll Medical Corporation, Cook Medical, Vitatron, St Jude Medical Inc and Cordis corporation.

Read the full report: https://www.reportlinker.com/p06370353/?utm_source=PRN

The global cardiac pacemakers market is expected to grow from $4.03 billion in 2021 to $4.26 billion in 2022 at a compound annual growth rate (CAGR) of 5.63%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The cardiac pacemakers market is expected to grow to $4.91 billion in 2026 at a compound annual growth rate (CAGR) of 3.62%.

The cardiac pacemakers market consists of sales of cardiac pacemaker devices by entities (organizations, sole traders, and partnerships) that are used to maintain the rhythm of heartbeats. A cardiac pacemaker refers to a small electronic device that generates electrical impulses and prevents the heart from beating too fast or slow and helps in treating heart conditions such as arrhythmias is a heart condition where the heart beats irregularly.

The main types of cardiac pacemakers include implantable and external implantable cardiac pacemakers is a device that generates electrical impulses to maintain the heart rate and are installed inside the chest through surgery.The different cardiac pacemaker technologies include biventricular, single-chambered, and dual-chambered.

The cardiac pacemaker applications include arrhythmias, heart blockage, atrial fibrillation, long QT syndrome, congestive cardiac failure, and other applications used by end-users including clinics and hospitals, ambulatory surgical centers, and cardiac care centers.

North America was the largest region in the cardiac pacemakers market in 2021.Asia Pacific is expected to be the fastest-growing region in the forecast period.

The regions covered in the cardiac pacemakers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

An increase in cardiovascular diseases is significantly contributing to the growth of the cardiac pacemaker market.Cardiovascular disease (CVD) refers to disorders that affect the heart or blood vessels.

These include arrhythmias, aorta disease, congenital heart disease, heart attack, and others.Cardiac pacemakers are electric activity-generating devices that are used to treat patients suffering from cardiovascular diseases.

According to World Health Organization statistics and the United Nations health organization, in 2019, 17.9 million people died from CVDs, accounting for 32% of all global deaths. Therefore, the rising incidence of cardiovascular diseases will drive the growth of cardiac pacemaker market.

New innovations are a key trend in the cardiac pacemaker market.Major players are making innovations like leadless cardiac pacemakers to cater to the cardiac pacemaker market in a better way.

The leadless pacemaker is a self-contained generator and electrode system and is 90% smaller than a transvenous pacemaker implanted immediately into the right ventricle.There is no need for a chest incision or subcutaneous generator pocket because the device is placed via a femoral vein transcatheter technique is a minimally invasive technique to repair an inadequately opening narrowed aortic valve.

For instance, in January 2022, Medtronic Plc, an Ireland-based medical devices company, introduced their leadless pacemaker Micra AV Transcatheter Pacing System (TPS). The Micra AV helps in patientsâ€™ treatment with AV block when the electrical communication between the heartâ€™s ventricle and atria is compromised.

In July 2022, Orchestra BioMed, a US-based company focused on developing transformative therapeutic products, collaborated with Medtronic.The collaboration between Medtronic and Orchestra BioMed is to develop BackBeat Cardiac Neuromodulation Therapy (CNT), a potential therapy for hypertension in people who need a cardiac pacemaker.

Medtronic is an Ireland-based company that provides healthcare technology.

The countries covered in the cardiac pacemakers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The cardiac pacemakers market research report is one of a series of new reports that provides cardiac pacemakers market statistics, including cardiac pacemakers industry global market size, regional shares, competitors with a cardiac pacemakers market share, detailed cardiac pacemakers market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac pacemakers industry. This cardiac pacemakers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Read the full report: https://www.reportlinker.com/p06370353/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001